- Even
with its cultivation facility only 20 percent operational, the company
reported record revenues from its first cannabis sales in 2018
- Flowr
announced that 20 fully constructed grow rooms will be available in Q3
2019, increasing its annual production capacity to 10,000 kilograms
- The
company has also announced plans to expand its product line with the sale
of seeds and clones once production is ramped up
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) registered
a number of important milestones in 2018, despite the fact that its world-class
cultivation facility was only 20 percent operational at the time. In an
official conference call held on April 4, 2019, the company announced its first
revenues on sales of premium cannabis in 2018. Flowr Corporation sold nearly
405 kilograms of cannabis produced at the grow rooms of its Kelowna 1
facility (http://ibn.fm/dhhdF).
Gross revenue reached C$3.3 million and net revenue was
established at C$2.9 million. The average net realized price was C$7.08 per
gram, after Flowr received its sales license in August 2018.
The Flowr cultivation facilities feature proprietary,
patent-pending systems designed to consistently generate high crop yields. The
84,000-square-foot flagship Kelowna 1 facility is located on a seven-acre
property in Kelowna, British Columbia. The facility is engineered to meet
pharmaceutical industry production standards for cleanliness.
Currently, 10 of the Kelowna 1 grow rooms are licensed for
use. Eight rooms are propagated with plants, and, by the end of the third
quarter of 2019, Flowr anticipates having 20 fully-constructed grow rooms. Once
that milestone is reached, Flowr Corporation’s cultivation capacity is expected
to ramp up to 10,000 kilograms of premium cannabis annually.
According to Flowr Co-CEO Vinay Tolia, the revenue numbers
are indicative of the company’s ability to grow and process a high-quality
product, even while only a fraction of the world-class Kelowna facility is
operational.
On top of completing the facility by the third quarter of
2019, Flowr also aims to expand its product line, as an official company
announcement detailed (http://ibn.fm/MdriE).
Flowr expects to start selling a selection of its premium high-quality cannabis
in clone and seed form to both national and international customers.
“As we ramp up production, we believe Flowr will be able to
offer the select cultivars we use to produce our premium cannabis to
cultivators globally,” company Co-CEO Tom Flow announced in a news release.
Mid-March 2019, Flowr Corporation also announced the launch
of its medical cannabis products for sale via the online Shoppers Drug Mart
platform (http://ibn.fm/egTA2).
Flowr Corporation and Shoppers Drug Mart confirmed a sales agreement at the
beginning of 2019. The collaboration will simplify the delivery of premium
medical cannabis products throughout Canada.
To order Flowr products online, patients need to submit a
completed medical document from their health care providers. Shoppers Drug Mart
advisors will next contact the health care practitioner for verification
purposes before products get shipped.
Previously, Flowr products were available online via the
company’s web portal. As per the new agreement, Shoppers Drug Mart is now the
exclusive direct-to-patient Flowr product distributor.
For more information, visit the company’s website at www.Flowr.ca
NOTE TO INVESTORS: The latest news and updates
relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment